100

서 론

. ,

2001 1,501 2007 101).

,

,

.

2,3),

4-6),

7,8),

9,10),

11,12),

13,14),

15,16),

17,18),

19,20),

21,22),

23,24)

.

,

2007 7 30 2007 8 2

2007 8 30

: , 9

302-122 1136

(Tel : 042-470-9481, Fax : 042-470-9005,

E-mail: ckson@dju.ac.kr)

손창규, 유사라

원 저

Market Analytic Study for Development of Korean Ginseng

Sa-ra Yoo, Chang-gue Son

Internal Department of Oriental Medicine College, Daejeon University

Objective : To build a basis of a research strategy for development of Korean ginseng as a global competitive

medical product in the world market by Korean Oriental medicine group.

Methods : Survey of all literature or analysis reports about market patterns related to ginseng or ginseng products

in Korea and in other countries.

Results : Korean ginseng and it products have rapidly decreased in share of the world market since the 1980s, with Korean ginseng occupying just 3% of the Hong Kong ginseng market in 2005. While Korean ginseng has been

satisfied with consumption within the large Korean market itself, it now has only 1% of world market share.

Conclusion : A systematic strategy is needed to strengthen global competitiveness of Korean ginseng based upon

development of novel customer-tailored ginseng products. In addition, experience and science-based research in the

Oriental medicine field should be involved in the process.

Key Words : Ginseng, Korean ginseng, market share, Oriental medicine

28 3 (2007 9 )J Korean Oriental Med 2007;28(3):100-107

1 :

101

3

30% 25).

,

. 200

1990

1 6500

.

30

.

500

10

110% 72%1).

, 2006

1560

17% ,

.

.

,

.

,

.

연구 방법

.

결과 및 고찰

1. 한국에서의 인삼의 재배와 생산량 변동추이

36,404 (1990 ) 15,793 (2005

) 15 43%

16% .

14,000 15,000

(table 1). 1

1978 (1990 ) 5808

3 ,

.

1990 1994 1998 2000 2001 2002 2003 2004 2005

( ) 36,404 30,500 22,170 23,011 19,310 23,430 18,106 13,797 15,793

(ha) 12,184 10,123 10,349 12,445 13,018 12,873 12,016 13,081 14,153

( ) 13,889 14,292 11,478 13,664 13,215 16,662 15,172 14,668 14,561

( ) 1,978 2,665 3,137 3,728 3,735 5,598 5,784 5,681 5,808

(607)

28 3 (2007 9 )

102

2. 한국에서의 인삼 제품의 생산과 시장 규모

.

. 1

( 1 5 , 2005 ) 7 1

.

2005

5 8 , 2

2 3 (table 2).

2

5 6

.

2

6

,

.

.

3. 한국 인삼 제품의 수출과 수입 실적

1990 1 6 5

2002 5 5

2006 8 9

(Fig. 1). 200

,

. 80~90%

2002

( , )

2003

( , )

2004

( , )

2005

( , )

, 4,529(1.6) 6,953(2.2) 11,683(3.3) 2,925(1.3)

5,344 (1.8) 4,901 (1.5) 4,817 (1.4) 1,139 (0.5)

10,257 (3.5) 5,607 (1.8) 9,652 (2.7) 4,174 (1.8)

3,781 (1.3) 7,581 (2.4) 3,461 (1.0) 739 (0.3)

8,667 (3.0) 8,388 (2.6) 6,897 (2.0) 7,559 (3.3)

11,538 (4.0) 13,934 (4.4) 13,355 (3.8) 13,002 (5.6)

, 63,749(22.4) 82,256(25.8) 91,145(25.7) 1,065 (0.5)

13,709 (4.7) 13,114 (4.1) 35,205 (9.9) 1,842 (0.8)

111,356(38.1) 101,918(32.0) 110,343(31.1) 153,724(66.6)

10,226 (3.5) 14,228 (4.5) 6,926 (2.0) 1,110 (0.5)

49,504(16.9) 60,055(18.8) 60,810(17.2) 43,601(18.9)

292,660(100) 318,935(100) 354,294(100) 230,880(100)

(608)

1 :

103

.

, ,

,

10 ,

2

(table 3).

,

,

.

4. 세계 인삼시장의 규모와 한국 인삼의 점유율

, ,

.

160

140

120

100

80

60

40

20

01990 1994 1998 2000 2002 2004 2006년

수출량 : 백만 불

7

6

5

4

3

2

1

01990 1994 1998 2000 2002 2004 2006년

수입량 : 백만 불

180

( ) 1998 1999 2000 2001 2002 2003 2004 2005 2006

58 7 20 13 28 10 74 100 23

17 7 10 42 0.4 32 31 47 192

7,804 6,091 4,172 4,586 4,971 2,591 2,594 3,699 4,397

259 133 218 281 176 20 494 818 1227

29,766 24,354 26,056 26,405 28,425 30,575 31,822 32,350 29,324

586 5,94.7 2,505 4,235 3,392 4,998 4,742 4,947 3483

31,864 40,899 43,255 31,977 8,886 22,714 40,882 32,205 34,495

0 127 474 290 422 162 274 59 191

12,515 12,975 5,483 11,785 12,726 11,286 13,788 14,094 20,359

29 54 37 46 25 78 129 197 236

(609)

28 3 (2007 9 )

104

.

:

70%28),

.

1

, , , ,

2005 229)

3% .

, ,

3%

(Fig 2).

: 2000

52,000 ,

70% ,

2 2 ,

, .

80%

,30)

.

,

(Table 4).

,

, 30%

2005 3

.27)

,

기타(0.6%)

일본(1.4%)

한국(2.9%)

대만(11.6%)

중국(11.9%)

대만(5.9%)

한국(3.1%)

원형삼 수입

기타(21.0%)

미국(21.7%)

중국(35.6%)

일본(7.2%)

싱가폴(5.7%)

캐나다(71.6%)

인삼제품 수입

2000 2001 2002 2003 2004 2005 2006

( ) 2,555 3,079 3,290 3,108 5,011 4,751 7,173

( ) 1,649 2,544 3,117 3,770 4,085 4,729 4710

(610)

1 :

105

.31)

:

2004 52

15% ,

.32)

(HS Code:

1302194020) 2005 745 2

1 (29.8 %)

. 28.7%

.32)

,

.

5. 한국 인삼의 경쟁력확보를 위한 전략과 한의

계의 역할

.

1% .

,

.

.

,

.

,

.

2003

( )

2004

( )

2005

( ) (%)

3,324 3,127 2,224 29.8

1,021 1,056 2,136 28.7

63 2,093 1,436 19.3

306 1,591 762 10.2

0 0 249 3.3

235 6 215 2.9

115 313 214 2.9

5,361 8,391 7,452 100

(611)

28 3 (2007 9 )

106

감사의 말씀

2007 ( )

(No. R01-2007-000-11248-0).

참고문헌

1. 2004 , ,

2005.

2. Larsen MW, Moser C, Hoiby N, Song Z,

Kharazmi A. Ginseng modulates the immune

response by induction of interleukin-12

production. APMIS. 2004;112:369-73.

3. Lee YS, Chung IS, Lee IR, Kim KH, Hong

WS, Yun YS. Activation of multiple effector

pathways of immune system by the antineop-

lastic immunostimulator acidic polysaccharide

ginsan isolated from Panax ginseng. Anticancer

Res. 1997;17:323-31.

4. Murphy LL, Lee TJ. Ginseng, sex behavior,

and nitric oxide. Ann N Y Acad Sci. 2002;

962:372-7.

5. Choi YD, Rha KH, Choi HK. In vitro and in

vivo experimental effect of Korean red ginseng

on erection. Urology. 1999;162: 1508-11.

6. Ryu JK, Lee T, Kim DJ, Park IS, Yoon SM,

Lee HS, Song SU, Suh JK. Free radical-

scavenging activity of Korean red ginseng for

erectile dysfunction in non-insulin-dependent

diabetes mellitus rats. Urology. 2005;65:611-5.

7. Kim SH, Park KS. Effects of Panax ginseng

extract on lipid metabolism in humans.

Pharmacol Res. 2003;48:511-3.

8. Yoon M, Lee H, Jeong S, Kim JJ, Nicol CJ,

Nam KW, Kim M, Cho BG, Oh GT. Perox-

isome proliferator-activated receptor alpha is

involved in the regulation of lipid metabolism

by ginseng. Br J Pharmacol. 2003;138:1295-

302.

9. Kumar M, Sharma MK, Saxena PS, Kumar A.

Radioprotective effect of Panax ginseng on the

phosphatases and lipid peroxidation level in

testes of Swiss albino mice. Biol Pharm Bull.

2003;26:308-12.

10. Kim EH, Jang MH, Shin MC, Shin MS, Kim

CJ. Protective effect of aqueous extract of

Ginseng radix against 1-methyl-4-phenylpy-

ridinium-induced apoptosis in PC12 cells. Biol

Pharm Bull. 2003;26:1668-73.

11. Sung J, Han KH, Zo JH, Park HJ, Kim CH,

Oh BH. Effects of red ginseng upon vascular

endothelial function in patients with essential

hypertension. Am J Chin Med. 2000;28:

205-16.

12. Han KH, Choe SC, Kim HS, Sohn DW, Nam

KY, Oh BH, Lee MM, Park YB, Choi YS,

Seo JD, Lee YW. Effect of red ginseng on

blood pressure in patients with essential

hypertension and white coat hypertension. Am

J Chin Med. 1998;26):199-209.

13. Xie JT, Wu JA, Mehendale S, Aung HH, Yuan

CS. Anti-hyperglycemic effect of the polysac-

charides fraction from American ginseng berry

extract in ob/ob mice. Phytomedicine. 2004;

11:182-7.

14. Dey L, Xie JT, Wang A, Wu J, Maleckar SA,

Yuan CS. Anti-hyperglycemic effects of

ginseng: comparison between root and berry.

Phytomedicine. 2003;10:600-5.

15. Kim JH, Hahm DH, Yang DC, Kim JH, Lee

HJ, Shim. Effect of crude saponin of Korean

red ginseng on high-fat diet-induced obesity

in the rat. J Pharmacol Sci. 2005;97:124-31.

16. Yun SN, Moon SJ, Ko SK, Im BO, Chung

SH. Wild ginseng prevents the onset of high-

(612)

1 :

107

fat diet induced hyperglycemia and obesity in

ICR mice. Arch Pharm Res. 2004; 27:790-6.

17. Kaneko H, Nakanishi KProof of the myste-

rious efficacy of ginseng: basic and clinical

trials: clinical effects of medical ginseng,

korean red ginseng: specifically, its anti-stress

action for prevention of disease. J Pharmacol

Sci. 2004;95:158-62.

18. Rai D, Bhatia G, Sen T, Palit GAnti-stress

effects of Ginkgo biloba and Panax ginseng:

a comparative study. J Pharmacol Sci. 2003;

93:458-64.

19. Voces J, Cabral de Oliveira AC, Prieto JG,

Vila L, Perez AC, Duarte ID, Alvarez AI.

Ginseng administration protects skeletal muscle

from oxidative stress induced by acute exercise

in rats. Braz J Med Biol Res. 2004; 37:1863-71.

20. Cabral de Oliveira AC, Perez AC, Merino G,

Prieto JG, Alvarez AI. Protective effects of

Panax ginseng on muscle injury and inflamm-

ation after eccentric exercise. Comp Biochem

Physiol C Toxicol Pharmacol. 2001; 130:369-77.

21. Wesnes KA, Ward T, McGinty A, Petrini O.

The memory enhancing effects of a Ginkgo

biloba/Panax ginseng combination in healthy

middle-aged volunteers. Psychopharmacology

(Berl). 2000;152:353-61.

22. Persson J, Bringlov E, Nilsson LG, Nyberg L.

The memory-enhancing effects of Ginseng and

Ginkgo biloba in healthy volunteers. Psycho-

pharmacology (Berl). 2004;172:430-4.

23. Helms S. Cancer prevention and therapeutics:

Panax ginseng. Altern Med Rev. 2004;9: 259-

74.

24. Yun TK.Experimental and epidemiological

evidence on non-organ specific cancer preventive

effect of Korean ginseng and identification of

active compounds. Mutat Res. 2003;523:63-74

25. 2005 ,

, 2006.

26. 2005 , , 2006

27. 2006 (www.kati.net),

. 2007

28. , , , , .

, J. Ginseng Res,

2006;30:165-171.

29. , , 2006

30. , , 2000

31. , , 2003

32. http://www.thinkfood.co.kr, , 2006

(613)